ArticleCancer biology & therapy2018

Cabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs.

Ekaterini Christina Tampaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.